ICON
ICON plc - Clinical Research Organisation (CRO) for Drug Development.
Launch date
Employees
Market cap
CAD33.9b
Enterprise valuation
CAD38.1b (Public information from Sep 2024)
Share price
$300.92001 ICLR
Ireland (HQ)
Financials
Estimates*
| EUR | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Revenues | 2.6b | 2.5b | 5.0b | 7.0b | 7.4b | 7.7b | 8.4b |
| % growth | 8 % | - | 96 % | 41 % | 5 % | 5 % | 8 % |
| EBITDA | 450m | 444m | 840m | 1.3b | 1.5b | - | - |
| % EBITDA margin | 18 % | 17 % | 17 % | 19 % | 20 % | - | - |
| Profit | 340m | 301m | 139m | 460m | 557m | - | - |
| % profit margin | 13 % | 12 % | 3 % | 7 % | 8 % | - | - |
| Date | Investors | Amount | Round |
|---|---|---|---|
| N/A | N/A | IPO | |
€4.0m | Grant | ||
* | N/A | $2.0b | Post IPO Debt |
| Total Funding | CAD6.0m | ||
Related Content
Recent News about ICON
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.
Investments by ICON
Edit
ACQUISITION by ICON Feb 2019
ACQUISITION by ICON Feb 2021
ACQUISITION by ICON Feb 2020
ACQUISITION by ICON Jan 2011
ACQUISITION by ICON Feb 2024
ACQUISITION by ICON May 2010
ACQUISITION by ICON Jul 2017